Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Follicular Thyroid Cancer Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Follicular Thyroid Cancer Drugmarket, defines the market attractiveness level of Follicular Thyroid Cancer Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Follicular Thyroid Cancer Drug industry, describes the types of Follicular Thyroid Cancer Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Follicular Thyroid Cancer Drug market and the development prospects and opportunities of Follicular Thyroid Cancer Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Follicular Thyroid Cancer Drug market in Chapter 13.
By Player:
Pfizer Inc
Novartis AG
Exelixis, Inc
AstraZeneca PLC
GlaxoSmithKline plc
By Type:
Cabozantinib S-Malate
Dabrafenib Mesylate
Everolimus
Sunitinib Malate
Others
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Follicular Thyroid Cancer Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Follicular Thyroid Cancer Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Follicular Thyroid Cancer Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Follicular Thyroid Cancer Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Follicular Thyroid Cancer Drug Market Analysis and Outlook to 2022
-
7.1 Global Follicular Thyroid Cancer Drug Consumption (2017-2022)
-
7.2 United States Follicular Thyroid Cancer Drug Consumption (2017-2022)
-
7.3 Europe Follicular Thyroid Cancer Drug Consumption (2017-2022)
-
7.4 China Follicular Thyroid Cancer Drug Consumption (2017-2022)
-
7.5 Japan Follicular Thyroid Cancer Drug Consumption (2017-2022)
-
7.6 India Follicular Thyroid Cancer Drug Consumption (2017-2022)
-
7.7 South Korea Follicular Thyroid Cancer Drug Consumption (2017-2022)
8 Region and Country-wise Follicular Thyroid Cancer Drug Market Analysis and Outlook to 2028
-
8.1 Global Follicular Thyroid Cancer Drug Consumption Forecast (2022-2028)
-
8.2 United States Follicular Thyroid Cancer Drug Consumption Forecast (2022-2028)
-
8.3 Europe Follicular Thyroid Cancer Drug Consumption Forecast (2022-2028)
-
8.4 China Follicular Thyroid Cancer Drug Consumption Forecast (2022-2028)
-
8.5 Japan Follicular Thyroid Cancer Drug Consumption Forecast (2022-2028)
-
8.6 India Follicular Thyroid Cancer Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Follicular Thyroid Cancer Drug Consumption Forecast (2022-2028)
9 Global Follicular Thyroid Cancer Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Follicular Thyroid Cancer Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Cabozantinib S-Malate Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Dabrafenib Mesylate Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Everolimus Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Sunitinib Malate Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Follicular Thyroid Cancer Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Follicular Thyroid Cancer Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Follicular Thyroid Cancer Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Cabozantinib S-Malate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Dabrafenib Mesylate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Everolimus Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Sunitinib Malate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Follicular Thyroid Cancer Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Follicular Thyroid Cancer Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Follicular Thyroid Cancer Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Follicular Thyroid Cancer Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Follicular Thyroid Cancer Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Follicular Thyroid Cancer Drug Market Competitive Analysis
-
14.1 Pfizer Inc
-
14.1.1 Pfizer Inc Company Details
-
14.1.2 Pfizer Inc Follicular Thyroid Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Inc Follicular Thyroid Cancer Drug Product and Service
-
14.2 Novartis AG
-
14.2.1 Novartis AG Company Details
-
14.2.2 Novartis AG Follicular Thyroid Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis AG Follicular Thyroid Cancer Drug Product and Service
-
14.3 Exelixis, Inc
-
14.3.1 Exelixis, Inc Company Details
-
14.3.2 Exelixis, Inc Follicular Thyroid Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Exelixis, Inc Follicular Thyroid Cancer Drug Product and Service
-
14.4 AstraZeneca PLC
-
14.4.1 AstraZeneca PLC Company Details
-
14.4.2 AstraZeneca PLC Follicular Thyroid Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AstraZeneca PLC Follicular Thyroid Cancer Drug Product and Service
-
14.5 GlaxoSmithKline plc
-
14.5.1 GlaxoSmithKline plc Company Details
-
14.5.2 GlaxoSmithKline plc Follicular Thyroid Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GlaxoSmithKline plc Follicular Thyroid Cancer Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Follicular Thyroid Cancer Drug
-
Figure Follicular Thyroid Cancer Drug Picture
-
Table Global Follicular Thyroid Cancer Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Follicular Thyroid Cancer Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Follicular Thyroid Cancer Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Follicular Thyroid Cancer Drug Consumption by Country (2017-2022)
-
Figure United States Follicular Thyroid Cancer Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Follicular Thyroid Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure China Follicular Thyroid Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Follicular Thyroid Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure India Follicular Thyroid Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Follicular Thyroid Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Follicular Thyroid Cancer Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Follicular Thyroid Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Follicular Thyroid Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Follicular Thyroid Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Follicular Thyroid Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Follicular Thyroid Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Follicular Thyroid Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cabozantinib S-Malate Consumption and Growth Rate (2017-2022)
-
Figure Global Dabrafenib Mesylate Consumption and Growth Rate (2017-2022)
-
Figure Global Everolimus Consumption and Growth Rate (2017-2022)
-
Figure Global Sunitinib Malate Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Cabozantinib S-Malate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dabrafenib Mesylate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Everolimus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sunitinib Malate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Follicular Thyroid Cancer Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Follicular Thyroid Cancer Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Follicular Thyroid Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Follicular Thyroid Cancer Drug Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Follicular Thyroid Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Follicular Thyroid Cancer Drug Product and Service
-
Table Exelixis, Inc (Foundation Year, Company Profile and etc.)
-
Table Exelixis, Inc Follicular Thyroid Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Exelixis, Inc Follicular Thyroid Cancer Drug Product and Service
-
Table AstraZeneca PLC (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca PLC Follicular Thyroid Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca PLC Follicular Thyroid Cancer Drug Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Follicular Thyroid Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Follicular Thyroid Cancer Drug Product and Service
-
